← Lisinopril

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Lisinopril

ACE inhibitor

Prepared 19 Sep 2026

What it is used for

Therapeutic use is agent- and indication-specific within the class (ACE inhibitor). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Hypertension, Congestive heart failure.

Warnings

Severe CCF, impaired renal function, lactation, aortic stenosis, NSAIDs, monitor serum lithium levels, first dose may cause hypotension especially in dehydrated cases, low sodium serum levels, diuretic treated cases, monitor renal function, may potentiate hypoglyceamic effects of insulin or oral hypoglycaemic agents, haematological monitoring. Avoid potassium sparing diuretics or potassium supplements. 11, 12, 16

Possible side effects

Persistent dry cough, voice changes, chest pain, taste disturbances, bronchospasm, blood dyscrasias, tachycardia, increased serum potassium levels, anaphylactic reactions, hepatic /renal impairment, hypotension, GI disturbances, muscle cramps, sleep disturbances, flushing, asthenia, impotence, CVS disorders.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage